Akorn, Inc.(AKRX): For the most recent quarter end, Akorn, Inc. reported Annual Earnings of $0.53. Based on the filings, last years Annual Earnings was, $1.95. For the most recent quarter end, AKRX reported a surprise Earnings per Share of 1.92% . The consensus estimate for current quarter is $0.55 and for the current fiscal year, the estimate is $2.17. For the Next fiscal year, the estimate is $2.12 based on the consensus.
Akorn, Inc. has received $0.55 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 7 Financial Advisor in the Stock Trading Firms. Among 7 Analysts, Bottom line EPS Estimate for the current quarter is $0.54 while the top line estimate is $0.56 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at -5.42%. Akorn, Inc. reported better than expected with a surprise EPS of 1.92% or $0.01 during its most recent quarterly earnings. The Actual EPS was $0.53 compared to the Estimated EPS of $0.52.
Akorn, Inc. has a Price to Earnings ratio of 9.96 for the trailing twelve month period. The price to book ratio of the company for the most recent quarter is 3.41. For the Most Recent Fiscal Year, Akorn, Inc. has a price to cash ratio of 7.34. For the Trailing twelve month period, company showed a Net Profit Margin of 16.58% and Return on Equity of the stock is 38.59%.
Akorn Last issued its quarterly earnings results on Nov 3, 2016. The company reported $0.56 EPS for the quarter, beating the analyst consensus estimate by $ 0.02. Analyst had a consensus of $0.54. The company had revenue of $284.10 million for the quarter, compared to analysts expectations of $266.70 million. The companys revenue was up 10.6% compared to the same quarter last year.
Company has reported several Insider transactions to the SEC, on Aug 16, 2016, Kenneth Abramowitz (director) sold 2,691 shares at 30.46 per share price.On Jun 14, 2016, Joseph Bonaccorsi (Sr VP Gen Counsel & Secretary) sold 6,500 shares at 29.84 per share price.On Jun 9, 2016, Ronald M Johnson (director) sold 7,542 shares at 31.49 per share price.
Akorn, Inc. (NASDAQ:AKRX) witnessed a decline in the market cap on Wednesday as its shares dropped 1.55% or 0.34 points. After the session commenced at $22, the stock reached the higher end at $22.075 while it hit a low of $21.48. With the volume soaring to 985,133 shares, the last trade was called at $21.57. The company has a 52-week high of $35.4. The company has a market cap of $2,701 million and there are 125,240,731 shares in outstanding. The 52-week low of the share price is $17.57.
Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products. Customers include physicians, optometrists, wholesalers, group purchasing organizations and other pharmaceutical companies. They also provide contract manufacturing services.